BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22747755)

  • 1. Acute myeloblastic leukemia with associated BCR-ABL translocation in a dog.
    Figueiredo JF; Culver S; Behling-Kelly E; Breen M; Friedrichs KR
    Vet Clin Pathol; 2012 Sep; 41(3):362-368. PubMed ID: 22747755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR-ABL translocation in a dog with chronic monocytic leukemia.
    Cruz Cardona JA; Milner R; Alleman AR; Williams C; Vernau W; Breen M; Tompkins M
    Vet Clin Pathol; 2011 Mar; 40(1):40-7. PubMed ID: 21143615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy.
    Culver S; Ito D; Borst L; Bell JS; Modiano JF; Breen M
    Vet Clin Pathol; 2013 Sep; 42(3):314-22. PubMed ID: 23800034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical chronic myeloid leukemia in a German Shepherd Dog.
    Marino CL; Tran JNSN; Stokol T
    J Vet Diagn Invest; 2017 May; 29(3):338-345. PubMed ID: 28205462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
    Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
    Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
    Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
    Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia.
    Manley R; Cochrane J; McDonald M; Rigby S; Moore A; Kirk A; Clarke S; Crossen PE; Morris CM; Patton WN
    Leukemia; 1999 Jan; 13(1):126-9. PubMed ID: 10049047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
    Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
    Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes.
    Chen Z; Morgan R; Berger CS; Pearce-Birge L; Stone JF; Sandberg AA
    Cancer Genet Cytogenet; 1993 Oct; 70(2):103-7. PubMed ID: 8242587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
    Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of BCR/ABL Fusion Gene by Hematological and Cytogenetical Analysis in Chronic Myeloid Leukemia Patients in Quetta, Pakistan.
    Tahira B; Asif M; Khan S; Hussain A; Shahwani MN; Malik A; Inayatullah S; Iqbal Z; Rasool M
    Asian Pac J Cancer Prev; 2015; 16(9):3793-7. PubMed ID: 25987039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of a second BCR-ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears.
    Cabot GP; Bentz M; Scholl C; Moos M; Fischer K; Lichter P; Döhner H
    Cancer Genet Cytogenet; 1996 Apr; 87(2):107-11. PubMed ID: 8625254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in laboratory medicine in chronic myeloid leukemia].
    Miura A
    Rinsho Byori; 1998 Dec; 46(12):1226-31. PubMed ID: 9916508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of the BCR-ABL fusion: Comparative analysis of six commercially available FISH fusion probes].
    Knas T; Buck M; Stegelmann F; Möller P; Barth TF
    Pathologe; 2015 Jul; 36(4):372-84. PubMed ID: 26175197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megakaryocyte features and bcr/abl translocation in chronic myeloid leukemia following imatinib mesylate (STI571) therapy--a fluorescence in-situ hybridization study.
    Thiele J; Kvasnicka HM; Varus E; Ollig E; Schmitt-Graeff A; Staib P; Griesshammer M
    Leuk Lymphoma; 2004 Aug; 45(8):1627-31. PubMed ID: 15370216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.